Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.

Patricia A. Ganz,Reena S. Cecchini,Julia White,Frank A. Vicini,Thomas B. Julian,Douglas W. Arthur,Rachel Rabinovitch,Robert R. Kuske,David S. Parda,Michael F. Scheier,Kathryn Winter,Soonmyung Paik,Henry Mark Kuerer,Laura A. Vallow,Lori J. Pierce,Eleftherios P. Mamounas,Joseph P. Costantino,Beryl McCormick,Walter J. Curran,Norman Wolmark

Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.

2019

508Background: PBI is an alternative to WBI, with potentially greater therapy (tx) compliance, and better integration with chemotherapy (CTX). NSABP B-39/RTOG 0413 clinical outcome results from 201...

Keywords:

Whole Breast Irradiation
Breast cancer
Partial Breast Irradiation
Oncology
Medicine
Internal medicine
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations